Inventor · disambiguated record
Walter H. Moos
Also filed as: MOOS WALTER · MOOS WALTER H
37 granted patents·3 pending applications·1,306 citations·filing 1983–2002
98Inventor score
Top patents by PatentIndex Score
40 records- 0198US5324483AApparatus for multiple simultaneous synthesisWARNER LAMBERT CO·Filed 1993·Granted Jun 28, 1994·400 cites·54 claims
- 0293US4786648AO-substituted tetrahydropyridine oxime cholinergic agentsWARNER LAMBERT CO·Filed 1987·Granted Nov 22, 1988·48 cites·27 claims
- 0392US5831005ASynthesis of N-substituted oligomersCHIRON CORP·Filed 1995·Granted Nov 3, 1998·90 cites·30 claims
- 0491US6511966B2Mitochondria protecting agents for treating mitochondria associated diseasesMITOKOR·Filed 2001·Granted Jan 28, 2003·31 cites·9 claims
- 0590US4710508AO-substituted tetrahydropyridine oxime cholinergic agentsWARNER LAMBERT CO·Filed 1986·Granted Dec 1, 1987·69 cites·42 claims
- 0688US5977301ASynthesis of N-substituted oligomersCHIRON CORP·Filed 1995·Granted Nov 2, 1999·59 cites·13 claims
- 0788US5612002AApparatus and method for multiple simultaneous synthesisWARNER LAMBERT CO·Filed 1995·Granted Mar 18, 1997·59 cites·36 claims
- 0887US4782071ATetrasubstituted urea cholinergic agentsWARNER LAMBERT CO·Filed 1986·Granted Nov 1, 1988·28 cites·25 claims
- 0984US4929734ATetrahydropyridine oxime compoundsWARNER LAMBERT CO·Filed 1988·Granted May 29, 1990·83 cites·6 claims
- 1082US4797419AMethod of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agentsWARNER LAMBERT CO·Filed 1986·Granted Jan 10, 1989·66 cites·14 claims
- 1181US4855308AMethod of treating senile cognitive decline with N'-substituted aminopyridine adrenergic agentsWARNER LAMBERT CO·Filed 1987·Granted Aug 8, 1989·17 cites·35 claims
- 1281US4657897AN6 -substituted adenosines for treating painWARNER LAMBERT CO·Filed 1985·Granted Apr 14, 1987·32 cites·12 claims
- 1380US6498191B2Mitochondria protecting agents for treating mitochondria associated diseasesMITOKOR·Filed 2000·Granted Dec 24, 2002·9 cites·4 claims
- 1480US4937239AAzabicycloalkane oxime & azabicycloalkene oxime muscarinic agentsWARNER LAMBERT CO·Filed 1989·Granted Jun 26, 1990·19 cites·11 claims
- 1578US4501735AN6-(1- and 2-benzocycloalkyl) adenosinesWARNER LAMBERT CO·Filed 1983·Granted Feb 26, 1985·17 cites·16 claims
- 1676US5346911AAzabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatmentWARNER LAMBERT CO·Filed 1993·Granted Sep 13, 1994·17 cites·12 claims
- 1775US4755594AN6 -substituted adenosinesWARNER LAMBERT CO·Filed 1986·Granted Jul 5, 1988·26 cites·26 claims
- 1873US4593019AN6 -tricyclic adenosinesWARNER LAMBERT CO·Filed 1984·Granted Jun 3, 1986·13 cites·12 claims
- 1972US4745123ASubstituted tetrahydro-3-pyridine-carboxylic acid, ester, and amide cholinergic agentsWARNER LAMBERT CO·Filed 1986·Granted May 17, 1988·17 cites·21 claims
- 2070US4791103A2,N6 -disubstituted adenosines, derivatives and methods of useWARNER LAMBERT CO·Filed 1985·Granted Dec 13, 1988·17 cites·48 claims
- 2170US4663313AN6 -tricyclic adenosines for treating hypertensionWARNER LAMBERT CO·Filed 1986·Granted May 5, 1987·17 cites·10 claims
- 2269US5536853AOpiate receptor ligandsCHIRON CORP·Filed 1994·Granted Jul 16, 1996·29 cites·13 claims
- 2368US6552076B2Compounds for altering mitochondrial function and cellular responsesMITOKOR·Filed 2001·Granted Apr 22, 2003·3 cites·18 claims
- 2467US4996201A4-(N-substituted amino)-2-butynyl-1-carbamates and thiocarbamates and derivatives thereof as centrally acting muscarinic agentsWARNER LAMBERT CO·Filed 1989·Granted Feb 26, 1991·8 cites·6 claims
- 2567US4798841ATetrahydropyridine oxime cholinergic agents and method of treatmentWARNER LAMBERT CO·Filed 1987·Granted Jan 17, 1989·15 cites·12 claims
- 2665US5306718AOxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatmentWARNER LAMBERT CO·Filed 1991·Granted Apr 26, 1994·17 cites·21 claims
- 2759US4657898AN6 -substituted adenosines and method of useWARNER LAMBERT CO·Filed 1985·Granted Apr 14, 1987·10 cites·14 claims
- 2858US4977172AMethod of treating the symptoms of cognitive decline in an elderly patient employing (S)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)-methyl]-2-oxazolidinoneWARNER LAMBERT CO·Filed 1989·Granted Dec 11, 1990·21 cites·11 claims
- 2955US2003176448A1Mitochondria protecting agents for treating mitochondria associated diseasesMITOKOR·Filed 2002·Application pending·0 cites
- 3054US5482938AAzabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatmentWARNER LAMBERT CO·Filed 1994·Granted Jan 9, 1996·9 cites·15 claims
- 3154US4999430ADerivatives of 1,2,3,4-tetrahydro-9-acrisinamineWARNER LAMBERT CO·Filed 1989·Granted Mar 12, 1991·6 cites·12 claims
- 3253US5480871APeptoid α-1 adrenergic receptor ligandsCHIRON CORP·Filed 1995·Granted Jan 2, 1996·17 cites·11 claims
- 3352US2002068750A1Mitochondria protecting agents for treating mitochondria associated diseasesFiled 2001·Application pending·0 cites
- 3452US2002065299A1Mitochondria protecting agents for treating mitochondria associated diseasesFiled 2001·Application pending·0 cites
- 3551US6887670B2Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays thereforMIGENIX CORP·Filed 2001·Granted May 3, 2005·0 cites·11 claims
- 3651US5447916APeptoid alpha-1 adrenergic receptor ligandsCHIRON CORP·Filed 1993·Granted Sep 5, 1995·15 cites·13 claims
- 3750US5073561AMethods of treating depression and psychosesWARNER LAMBERT CO·Filed 1990·Granted Dec 17, 1991·4 cites·2 claims
- 3850US4960815AIsotopically-labeled polycyclic amine derivativesWARNER LAMBERT CO·Filed 1990·Granted Oct 2, 1990·13 cites·4 claims
- 3948US5081304AIsotopically-labeled polycyclic amine derivativesWARNER LAMBERT CO·Filed 1990·Granted Jan 14, 1992·3 cites·1 claims
- 4042US4988688A4-(N-substituted amino)-2-butynyl-1-ureas and thioureas and derivatives thereof as centrally acting muscarinic agentsWARNER LAMBERT CO·Filed 1989·Granted Jan 29, 1991·2 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Walter H. Moos files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →